Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lyell Immunopharma (LYEL) Gains from Investment Securities (2020 - 2024)

Lyell Immunopharma (LYEL) has disclosed Gains from Investment Securities for 5 consecutive years, with $13.0 million as the latest value for Q1 2024.

  • Quarterly Gains from Investment Securities rose 30.01% to $13.0 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $13.0 million through Dec 2024, changed 0.34% year-over-year, with the annual reading at $1000.0 for FY2025, 98.68% down from the prior year.
  • Gains from Investment Securities hit $13.0 million in Q1 2024 for Lyell Immunopharma, up from $123000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $43.6 million in Q3 2021 to a low of -$4.5 million in Q4 2022.
  • Historically, Gains from Investment Securities has averaged $10.2 million across 5 years, with a median of $5.5 million in 2020.
  • Biggest five-year swings in Gains from Investment Securities: soared 629.42% in 2021 and later crashed 112.47% in 2022.
  • Year by year, Gains from Investment Securities stood at $7.0 million in 2020, then soared by 419.93% to $36.4 million in 2021, then plummeted by 112.47% to -$4.5 million in 2022, then surged by 102.71% to $123000.0 in 2023, then soared by 10469.92% to $13.0 million in 2024.
  • Business Quant data shows Gains from Investment Securities for LYEL at $13.0 million in Q1 2024, $123000.0 in Q4 2023, and $2.9 million in Q2 2023.